Genetically engineered anti-glioma CTL’s in a murine model of EGFRvIII expressing tumors

Principal Investigator: Bob S. Carter, MD, PhD

Institute: Massachusetts General Hospital

Initiative: Unrestricted Grant

Location: Boston, MA

Share